October 28, 2025- Cleveland Clinic is establishing a new initiative in cardiovascular genomics that will integrate genomic information into clinical care and research to advance how heart disease is detected, prevented, and treated.
The new program will include two complementary components within the Heart, Vascular and Thoracic Institute (HVTI):
- The Center for Cardiovascular Genomics and Data Sciences, which will lead investigative efforts in discovery genomics, genomic risk prediction, and translational science.
- The Haslam-Bailey Family Section of Cardiovascular Genomics and Precision Medicine, which was created from a generous gift by the Haslam-Bailey families and will integrate clinical genomic testing, counseling, and interpretation into routine cardiovascular care, while serving as a platform to rapidly incorporate advances in genomic science into patient management.